ACT announces receipt of NIH grant to support first in human clinical trial development and execution for an implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma

AUG

28

Use of iontophoresis for the treatment of cancer

JUL

31

‘In MedTech History’ - Oncology Device Technology

MAY

16

Implantable Device to Deliver Chemo to Pancreatic Cancer Tumors

MAY

14

Cancer life-saver? UNC spinout developing device for better chemo delivery

MAY

11

UNC Spinout Developing Device for Better Chemo Delivery

JAN

16

Narrowing the gap toward precision medicine for pancreatic cancer

SEP

21

ACT announces receipt of NIH grant to support research into the implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma

FEB

23

Device targets hard-to-treat pancreatic cancer

Advanced Chemotherapy Technologies, Inc.

111 James Jackson Avenue, Suite 131

Cary North Carolina 27513-3598

| Contact | Privacy Policy | Terms and Conditions |

Advanced Chemotherapy Technologies, Inc. Announces Issuance of US Patent for an Interventional Drug Delivery System

Notice of Allowance Received from U.S. Patent and Trademark Office for Patent Application with Claims Covering Combination Iontophoresis and Radiation Therapy

ACT announces receipt of Phase II NIH grant to support device development and first-in-human clinical trial for implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma

Leading the way toward greater hope for pancreatic cancer patients

ACT announces receipt of NIH grant to support first in human clinical trial development and execution for an implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma